南北アメリカ・欧州の点眼薬市場規模・予測、世界と地域別のシェア、動向、成長機会分析：薬剤クラス、用途、購入形態、地域別

南北アメリカ・欧州の点眼薬の市場規模は、2023年に131億6,000万米ドルに達し、2023年～2031年にCAGR5.3%で成長し、2031年には198億8,000万米ドルに達すると予測されています。 眼科疾患の有病率の上昇と加齢に伴う眼疾患の発生率の高さが、南北アメリカ・欧州の点眼薬市場の成長を後押ししています。

眼病に悩む人々の多くは、特別な点眼薬を必要としています。これらの眼病は点眼薬で治療でき、より効果的で痛みも少ないです。ドライアイ、充血、痛み、かゆみ、緑内障、屈折異常、結膜炎、糖尿病黄斑浮腫、加齢黄斑変性などの症状は、これらの製品を使用して効果的に治療することができます。人工涙液とも呼ばれる点眼薬は、一般的に使用される治療薬の一種で、目に潤いを与え、さらなる感染から目を保護することで、ドライアイや炎症性の目の症状を同時に緩和します。汚染、ライフスタイルの変化、長時間のスクリーン使用は、目の痛みの顕著な原因です。これらの要因や環境条件が、緩和と保護を提供する点眼薬の需要を後押ししています。処方箋なしで購入できる幅広い種類の点眼薬が入手可能になったことで、顧客の調達が容易になりました。

眼科疾患の有病率の上昇が南北アメリカ・欧州の点眼薬市場を牽引

糖尿病性網膜症、緑内障、ドライアイ（DED）などの眼科疾患の罹患率は、様々な国、特に先進国の人口において上昇しています。DEDは患者に不快感、炎症、視覚障害を引き起こします。糖尿病網膜症は微小血管の末端器官障害を示します。非増殖糖尿病網膜症の段階から増殖糖尿病網膜症へと進行します。進行すると糖尿病黄斑浮腫（DME）が現れ、視力障害や失明に至ることもあります。「国民健康・福祉調査」によると、2020年4月の時点で、米国では最大1,640万人がドライアイと診断されています。この調査では、2020年中に18～34歳の有病率が2.7％上昇することが強調されています。ノバリクによると、2023年の時点で、欧州では1,300万人、南北アメリカでは1,700万人がDEDに罹患しています。参天製薬によると、2021年には欧州では11～30％の人がDEDに罹患しています。Medscapeのウェブサイトに掲載されたデータによると、米国では最大70万人が増殖糖尿病網膜症に罹患しており、毎年最大6万5,000人が新たに発症しています。さらに、国際糖尿病連合欧州によれば、糖尿病患者の20～35％が糖尿病網膜症を発症するリスクがあります。欧州では、1型糖尿病患者におけるDMEの有病率は約8.8％です。

高齢者に多い白内障は、目の水晶体に濁った部分ができるのが特徴です。BMJ誌に掲載された論文"Cataract surgery practice patterns worldwide：a survey "によると、白内障の摘出はすべての診療科において最も一般的な外科手術であり、米国では年間推定370万例、欧州では700万例が報告されています。Eurostatによると、白内障手術はEUで最も一般的な外科手術であり、2021年の手術件数は432万件でした。参天製薬によると、緑内障の患者数は2040年までに欧州で785万人に急増すると推定されています。

医師は一般的に、様々な眼科疾患の治療、予防、術後のケアのために点眼薬を処方します。したがって、眼科疾患の有病率の増加は、南北アメリカ・欧州の点眼薬市場の成長を促進します。

市場動向

目の健康に影響を与えるライフスタイルの変化

ライフスタイルの要因は、全体的な健康と幸福に影響を与える可能性があります。食事、フィットネス、野外活動など、人々が毎日行う選択は、その人の老化の程度に影響を与えます。加齢のプロセスは、目の健康と視力の変化も伴います。頻繁に強い日差しを浴びると、眼病を発症するリスクが高まります。米国眼科学会によると、太陽の紫外線を浴びると、黄斑変性症や白内障のリスクが高まるといいます。太りすぎは、いくつかの点で目の病気のリスクを高めます。太り過ぎや肥満は糖尿病の発症リスクを高め、糖尿病性網膜症や緑内障などの病気による視力低下を招きます。さらに、生活の質を向上させるために服用する非処方薬も、処方薬と同様の副作用を引き起こす可能性があります。近年、DEDの使用事例が急増しているのは、コンピュータの使用増加により、視覚表示装置（VDT）に長時間さらされることが原因であると考えられています。日常生活のさまざまな場面で、眼表面や眼球に予期せぬ影響を及ぼすことがあります。スマートフォン、ノートパソコン、コンピューターの使用増加は、眼疾患の主な危険因子のひとつです。したがって、これらの疾患は生活習慣病全体の中でかなりの割合を占めています。このように、スクリーン使用時間の増加は現代人のライフスタイルの重要な側面となっており、眼に関連する問題を引き起こす原因となっています。慢性的な眼疾患や屈折異常のある人は、デジタル眼精疲労（DES）を発症するリスクが高いです。DESは多くの場合、不快感、目の乾き、目のかすみ、頭痛として現れます。スマートフォン、タブレット、iPad、ノートパソコンの画面から発せられる青色光線に過度にさらされることも、深刻な眼障害を引き起こします。

COVID-19が大流行した際、すべての企業は病気の蔓延を抑えるために在宅勤務（WFH）モデルを採用しました。WFHの動向は、社会人のスクリーン使用時間を増加させ、目に関連する問題をさらに加速させています。Frontiers誌に発表された研究によると、デジタル機器を連続2時間以上使用し続けると、過剰な調節力が要求されるため、DESを発症する危険性が高いとのことです。COVID-19の蔓延はかなり抑制されていますが、多くの企業は従業員にWFHを続けさせ、全体的な支出を減らしています。このようなライフスタイルの変化は、長期的には目の健康に悪影響を及ぼし、将来的に点眼薬の需要を増加させると予想されます。

南北アメリカ・欧州の点眼薬市場は薬剤クラス別、用途別、購入形態別、地域別に区分されています。

薬剤クラス別の洞察

薬剤クラス別では、抗生物質、人工涙液、ステロイド、その他に区分されます。2023年には抗生物質セグメントが最大の市場シェアを占めています。しかし、ステロイドセグメントは予測期間中に6.4%という最高のCAGRを記録すると予測されています。抗生物質点眼薬は、抗菌性感染症を治療するために医師によって処方されます。これらの点眼薬の作用は、感染症に作用する前に目の複数の組織層に浸透することから始まります。ほとんどの場合、抗生物質入りの点眼薬はすぐに症状を緩和します。ほとんどの抗生物質点眼薬は安全で、副作用も少ないです。点眼薬の抗生物質には、クロラムフェニコール、エリスロマイシン、アジスロマイシン、シプロフロキサシン、ネオマイシン、モキシフロキサシン、トブラマイシン、バシトラシン、ゲンタマイシン、ポリミキシンB、ガチフロキサシン、ベシフロキサシン、レボフロキサシンなどがあります。有効性に加え、マイボーム腺の機能不全を改善する有益な役割が、抗生物質点眼薬市場の成長に寄与しています。

用途別の洞察

南北アメリカ・欧州の点眼薬市場は、用途別に眼科疾患、アイケア、その他に区分されます。2023年には、眼疾患セグメントが最大の市場シェアを占めています。しかし、アイケアセグメントは予測期間中に最も高いCAGRを記録すると予測されています。

米国食品医薬品局、世界保健機関、疾病管理予防センター、国連人口活動基金、世界疾病負担は、アメリカ・欧州の点眼薬市場調査報告書を作成する際に参照した関連情報源の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

• 主要な洞察

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 南北アメリカ・欧州の点眼薬市場情勢

• 概観
• PEST分析

第5章 南北アメリカ・欧州の点眼薬市場力学

• 南北アメリカ・欧州の点眼薬市場- 主要市場力学
• 市場促進要因
  • 眼科疾患の有病率の上昇
  • 加齢に伴う眼疾患の高い発生率
• 市場抑制要因
  • 製品リコールの増加
• 市場機会
  • 眼科医療に対する意識向上への取り組み
• 今後の動向
  • 目の健康に影響を与えるライフスタイルの変化
• 影響

第6章 南北アメリカ・欧州の点眼薬市場：地域別市場分析

• 南北アメリカ・欧州の点眼薬市場収益（2023年～2031年）

第7章 南北アメリカ・欧州の点眼薬市場分析：薬剤クラス別

• 抗生物質
• 人工涙液
• ステロイド
• その他

第8章 南北アメリカ・欧州の点眼薬市場分析：用途別

• 眼疾患
• アイケア
• その他

第9章 南北アメリカ・欧州の点眼薬市場分析：購入形態別

• 処方箋
• 一般用医薬品

第10章 南北アメリカ・欧州の点眼薬市場：地域別分析

• 南北アメリカ
  • 南北アメリカの点眼薬市場概要
• 欧州

第11章 業界情勢

• 南北アメリカ・欧州の点眼薬市場における成長戦略
• 有機的成長戦略
• 無機的成長戦略

第12章 企業プロファイル

• Alcon AG
• AbbVie Inc
• Bausch & Lomb Inc
• Pfizer Inc
• Prestige Consumer Healthcare Inc.
• Similasan Corp
• Rohto Pharmaceutical Co Ltd
• Sager Pharma Kft
• Akorn Operating Company LLC
• Santen Pharmaceutical Co., Ltd.
• SERVImed Industrial S.p.A.
• I-MED Pharma Inc.

第13章 付録

List Of Tables

• Table 1. America and Europe Eye Drops Market Segmentation
• Table 2. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 3. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 4. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 5. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 6. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 7. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 8. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 9. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 10. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 11. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 12. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 13. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 14. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 15. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 16. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 17. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 18. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 19. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 20. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 21. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 22. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 23. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 24. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 25. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 26. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 27. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 28. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 29. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 30. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 31. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 32. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 33. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 34. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 35. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 36. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 37. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 38. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 39. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 40. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 41. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 42. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 43. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 44. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 45. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 46. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 47. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 48. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 49. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 50. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 51. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 52. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 53. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 54. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 55. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 56. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 57. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 58. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 59. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 60. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 61. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 62. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 63. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 64. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 65. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 66. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 67. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 68. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 69. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 70. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 71. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 72. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 73. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 74. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 75. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 76. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 77. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 78. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 79. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 80. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 81. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 82. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 83. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 84. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 85. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 86. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 87. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 88. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 89. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 90. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 91. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 92. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 93. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 94. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 95. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 96. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 97. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 98. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 99. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 100. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Drug Class
• Table 101. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Antibiotics
• Table 102. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Artificial Tears
• Table 103. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Steroids
• Table 104. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Application
• Table 105. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Eye Diseases
• Table 106. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million) - by Purchase Mode
• Table 107. Recent Organic Growth Strategies in the America and Europe Eye Drops Market
• Table 108. Recent Inorganic Growth Strategies in the America and Europe Eye Drops Market

List Of Figures

• Figure 1. America and Europe Eye Drops Market Segmentation, by Geography
• Figure 2. PEST Analysis
• Figure 3. Impact Analysis of Drivers and Restraints
• Figure 4. America and Europe Eye Drops Market Revenue (US$ Million), 2023-2031
• Figure 5. Eye Drops Market Breakdown by Geography, 2023 and 2031 (%)
• Figure 6. America and Europe Eye Drops Market Share (%) - by Drug Class (2023 and 2031)
• Figure 7. Antibiotics: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 8. Artificial Tears: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 9. Steroids: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 10. Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 11. America and Europe Eye Drops Market Share (%) - by Application (2023 and 2031)
• Figure 12. Eye Diseases: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 13. Eye Care: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 14. Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 15. America and Europe Eye Drops Market Share (%) - by Purchase Mode (2023 and 2031)
• Figure 16. Prescription: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 17. OTC: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 18. America and Europe Eye Drops Market Breakdown by Region, 2023 and 2031 (%)
• Figure 19. America: Eye Drops Market, by Key Country - Revenue (2023) (US$ Million)
• Figure 20. America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 21. America: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 22. United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 23. Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 24. Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 25. Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 26. Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 27. Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 28. Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 29. Europe: Eye Drops Market, by Key Country - Revenue (2023) (US$ Million)
• Figure 30. Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 31. Europe: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 32. Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 33. France: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 34. United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 35. Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 36. Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 37. Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031(US$ Million)
• Figure 38. Growth Strategies in the America and Europe Eye Drops Market

The America & Europe eye drops market size is projected to surge from US$ 13.16 billion in 2023 to US$ 19.88 billion by 2031; the market is estimated to record a CAGR of 5.3% during 2023-2031. The rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases propel the America & Europe eye drops market growth.

Most people who suffer from eye problems need special eye drops. These eye diseases can be treated with eye drops, which are more effective and less painful. Symptoms such as dry eye, redness, pain, itching, glaucoma, refractive error, conjunctivitis, diabetic macular edema, and age-related macular degeneration can be effectively treated using these products. Eye drops, also called artificial tears, are a class of therapeutics commonly used to simultaneously relieve the symptoms of dry and irritated eyes by moisturizing the eyes and protecting them from further infection. Pollution, changing lifestyles, and prolonged screen time are the prominent causes of eye pain. These factors and environmental conditions propel the demand for eye drops that provide relief and protection. The availability of a wide range of eye drops that can be purchased without a prescription has made it easier for customers to procure them.

Rising Prevalence of Ophthalmic Diseases Drives the America & Europe Eye Drops Market

The Incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye disease (DED) is rising in the populations of various countries, especially the developed ones. DED causes discomfort, irritation, and visual disturbance in patients. Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema (DME) may also become apparent, leading to vision problems and blindness. According to the "National Health and Wellness Survey," ~16.4 million people were detected with dry eye in the US as of April 2020. The study highlights an upsurge in prevalence by 2.7% among people aged 18-34 years during 2020. According to Novaliq GmbH, ~13 million Europeans and ~17 million Americans suffered from DED as of 2023. As per Santen Pharmaceuticals, nearly 11-30% of people in Europe suffered from DED in 2021. Data released on Medscape website states that ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually. Further, as per the International Diabetes Federation Europe, 20-35% of people with diabetes are at risk of developing diabetic retinopathy. The prevalence of DME in people with type 1 diabetes is approximately 8.8% in Europe.

Cataracts, which are highly common in elderly people, are characterized by the formation of a cloudy area in the eye lens. According to the article "Cataract surgery practice patterns worldwide: a survey," published in BMJ, cataract extraction is the most common surgical procedure in all medical specialties, with an estimated 3.7 million cases per year in the US and 7 million cases reported in Europe. As per Eurostat, cataract surgery was the most common surgical procedure in the EU, with 4.32 million operations in 2021. According to Santen Pharmaceuticals, the number of people suffering from glaucoma is estimated to soar up to ~7.85 million in Europe by 2040.

Doctors generally prescribe eye drops for the treatment, prevention, and post-surgical care of various ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases fuels the America & Europe eye drops market growth.

Market Trend

Lifestyle Changes Affecting Eye Health

Lifestyle factors can impact the overall health and well-being. The choices made by people every day with regard to their food, fitness, outdoor activities, etc., affect how well they age. The aging process also involves changes in eye health and vision. Heavy sun exposure on a frequent basis can increase the risk of developing eye diseases. As per the American Academy of Ophthalmology, exposure to the sun's UV rays can increase the risk of macular degeneration and cataracts. Being overweight can increase the risk of eye problems in several ways. Overweight and obesity increase the risk of developing diabetes, which can lead to vision loss from diseases such as diabetic retinopathy and glaucoma. Further, non-prescription medications taken to improve quality of life can also cause side effects similar to those of prescription medications. The rapid increase in DED cases in recent years is believed to be due to prolonged exposure to visual display devices (VDT) caused by increasing computer use. Many aspects of everyday life can have unforeseen effects on the ocular surface and the eye. The increased use of smartphones, laptops, and computers is one of the key risk factors for eye diseases. Hence, these diseases hold a substantial share of the overall category of lifestyle diseases. Thus, increased screen time has become an important aspect of a modern lifestyle, which is responsible for triggering eye-related problems. Individuals with chronic eye conditions and refractive errors are at a greater risk of developing digital eye strain (DES). DES often manifests as discomfort, dryness, blurred vision, and headaches. Extreme exposure to blue rays emitted from smartphone, tablet, iPad, and laptop screens also causes serious eye damage.

During the COVID-19 pandemic, all companies opted to adopt the work-from-home (WFH) model to control the disease spread. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by Frontiers, the constant use of digital devices for more than two continuous hours puts users at a great risk of developing DES owing to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. Such lifestyle changes are eventually expected to have negative effects on eye health in the long run, generating a greater demand for eye drops in the future.

The "America & Europe Eye Drops Market" is segmented on the basis of drug class, application, purchase mode, and geography.

Drug Class-Based Insights

Based on drug class, the America & Europe eye drops market is segmented into antibiotics, artificial tears, steroids, and others. The antibiotics segment held the largest market share in 2023. However, the steroids segment is anticipated to register the highest CAGR of 6.4% during the forecast period. Antibiotic eye drops are prescribed by doctors to treat antibacterial infections. The action of these eye drops starts with the penetration of multiple tissue layers of the eye before acting on the infection. In most cases, antibiotic eye drops provide immediate relief from the condition. Most antibiotic eye drops are safe and have minimal side effects. Different antibiotics that are offered in the form of eye drops include chloramphenicol, erythromycin, azithromycin, ciprofloxacin, neomycin, moxifloxacin, tobramycin, bacitracin, gentamycin, polymyxin B, gatifloxacin, besifloxacin, and levofloxacin. In addition to their efficacy, their beneficial role in rectifying the malfunctioning of meibomian glands contributes to the growth of the market for antibiotic eye drops.

Application-Based Insights

Based on process, the America & Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest market share in 2023. However, the eye care segment is anticipated to register the highest CAGR during the forecast period.

US Food and Drug Administration, World Health Organization, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, United Nations Fund for Population Activities, and Global Burden of Disease are some of the relevant sources referred while preparing the America & Europe eye drops market research report.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. America and Europe Eye Drops Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. America and Europe Eye Drops Market - Key Market Dynamics

• 5.1 America and Europe Eye Drops Market - Key Market Dynamics
• 5.2 Market Drivers
  • 5.2.1 Rising Prevalence of Ophthalmic Diseases
  • 5.2.2 High Incidence of Age-Related Eye Diseases
• 5.3 Market Restraints
  • 5.3.1 Rising Number of Product Recalls
• 5.4 Market Opportunities
  • 5.4.1 Initiatives to Bolster Eye Care Awareness
• 5.5 Future Trends
  • 5.5.1 Lifestyle Changes Affecting Eye Health
• 5.6 Impact:

6. America and Europe Eye Drops Market - Regional Market Analysis

• 6.1 America and Europe Eye Drops Market Revenue (US$ Million), 2023-2031

7. America and Europe Eye Drops Market Analysis - by Drug Class

• 7.1 Overview
• 7.2 Antibiotics
  • 7.2.1 Overview
  • 7.2.2 Antibiotics: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• 7.3 Artificial Tears
  • 7.3.1 Overview
  • 7.3.2 Artificial Tears: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• 7.4 Steroids
  • 7.4.1 Overview
  • 7.4.2 Steroids: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• 7.5 Others
  • 7.5.1 Overview
  • 7.5.2 Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

8. America and Europe Eye Drops Market Analysis - by Application

• 8.1 Overview
• 8.2 Eye Diseases
  • 8.2.1 Overview
  • 8.2.2 Eye Diseases: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• 8.3 Eye Care
  • 8.3.1 Overview
  • 8.3.2 Eye Care: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• 8.4 Others
  • 8.4.1 Overview
  • 8.4.2 Others: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

9. America and Europe Eye Drops Market Analysis - by Purchase Mode

• 9.1 Overview
• 9.2 Prescription
  • 9.2.1 Overview
  • 9.2.2 Prescription: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
• 9.3 OTC
  • 9.3.1 Overview
  • 9.3.2 OTC: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)

10. America and Europe Eye Drops Market - Geographical Analysis

• 10.1 Overview
• 10.2 America
  • 10.2.1 America Eye Drops Market Overview
  • 10.2.2 America: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.2.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Drug Class
      • 10.2.2.1.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Antibiotics
      • 10.2.2.1.2 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Artificial Tears
      • 10.2.2.1.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Steroids
    • 10.2.2.2 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Application
      • 10.2.2.2.1 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Eye Diseases
    • 10.2.2.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Purchase Mode
  • 10.2.3 America: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Country
    • 10.2.3.1 United States: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.1.1 Overview
      • 10.2.3.1.2 United States: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.1.3 United States: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.2.3.1.3.1 United States: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.2.3.1.3.2 United States: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.2.3.1.3.3 United States: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.2.3.1.4 United States: America and Europe Eye Drops Market Breakdown, by Application
      • 10.2.3.1.4.1 United States: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.2.3.1.5 United States: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.2.3.2 Canada: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.2.1 Overview
      • 10.2.3.2.2 Canada: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.2.3 Canada: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.2.3.2.3.1 Canada: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.2.3.2.3.2 Canada: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.2.3.2.3.3 Canada: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.2.3.2.4 Canada: America and Europe Eye Drops Market Breakdown, by Application
      • 10.2.3.2.4.1 Canada: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.2.3.2.5 Canada: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.2.3.3 Brazil: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.3.1 Overview
      • 10.2.3.3.2 Brazil: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.2.3.3.3.1 Brazil: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.2.3.3.3.2 Brazil: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.2.3.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.2.3.3.4 Brazil: America and Europe Eye Drops Market Breakdown, by Application
      • 10.2.3.3.4.1 Brazil: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.2.3.3.5 Brazil: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.2.3.4 Mexico: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.4.1 Overview
      • 10.2.3.4.2 Mexico: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.4.3 Mexico: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.2.3.4.3.1 Mexico: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.2.3.4.3.2 Mexico: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.2.3.4.3.3 Mexico: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.2.3.4.4 Mexico: America and Europe Eye Drops Market Breakdown, by Application
      • 10.2.3.4.4.1 Mexico: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.2.3.4.5 Mexico: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.2.3.5 Argentina: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.5.1 Overview
      • 10.2.3.5.2 Argentina: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.5.3 Argentina: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.2.3.5.3.1 Argentina: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.2.3.5.3.2 Argentina: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.2.3.5.3.3 Argentina: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.2.3.5.4 Argentina: America and Europe Eye Drops Market Breakdown, by Application
      • 10.2.3.5.4.1 Argentina: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.2.3.5.5 Argentina: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.2.3.6 Chile: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.6.1 Overview
      • 10.2.3.6.2 Chile: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.6.3 Chile: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.2.3.6.3.1 Chile: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.2.3.6.3.2 Chile: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.2.3.6.3.3 Chile: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.2.3.6.4 Chile: America and Europe Eye Drops Market Breakdown, by Application
      • 10.2.3.6.4.1 Chile: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.2.3.6.5 Chile: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.2.3.7 Rest of America: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.7.1 Overview
      • 10.2.3.7.2 Rest of America: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.2.3.7.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.2.3.7.3.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.2.3.7.3.2 Rest of America: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.2.3.7.3.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.2.3.7.4 Rest of America: America and Europe Eye Drops Market Breakdown, by Application
      • 10.2.3.7.4.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.2.3.7.5 Rest of America: America and Europe Eye Drops Market Breakdown, by Purchase Mode
• 10.3 Europe
  • 10.3.1 Overview
  • 10.3.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.2.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Drug Class
      • 10.3.2.1.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Antibiotics
      • 10.3.2.1.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Artificial Tears
      • 10.3.2.1.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Steroids
    • 10.3.2.2 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Application
      • 10.3.2.2.1 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Eye Diseases
    • 10.3.2.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Purchase Mode
  • 10.3.3 Europe: America and Europe Eye Drops Market - Revenue and Forecast Analysis - by Country
    • 10.3.3.1 Germany: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.1.1 Overview
      • 10.3.3.1.2 Germany: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.1.3 Germany: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.3.3.1.3.1 Germany: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.3.3.1.3.2 Germany: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.3.3.1.3.3 Germany: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.3.3.1.4 Germany: America and Europe Eye Drops Market Breakdown, by Application
      • 10.3.3.1.4.1 Germany: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.3.3.1.5 Germany: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.3.3.2 France: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.2.1 Overview
      • 10.3.3.2.2 France: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.2.3 France: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.3.3.2.3.1 France: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.3.3.2.3.2 France: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.3.3.2.3.3 France: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.3.3.2.4 France: America and Europe Eye Drops Market Breakdown, by Application
      • 10.3.3.2.4.1 France: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.3.3.2.5 France: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.3.3.3 United Kingdom: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.3.1 Overview
      • 10.3.3.3.2 United Kingdom: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.3.3.3.3.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.3.3.3.3.2 United Kingdom: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.3.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.3.3.3.4 United Kingdom: America and Europe Eye Drops Market Breakdown, by Application
      • 10.3.3.3.4.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.3.3.3.5 United Kingdom: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.3.3.4 Italy: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.4.1 Overview
      • 10.3.3.4.2 Italy: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.4.3 Italy: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.3.3.4.3.1 Italy: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.3.3.4.3.2 Italy: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.3.3.4.3.3 Italy: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.3.3.4.4 Italy: America and Europe Eye Drops Market Breakdown, by Application
      • 10.3.3.4.4.1 Italy: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.3.3.4.5 Italy: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.3.3.5 Spain: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.5.1 Overview
      • 10.3.3.5.2 Spain: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.5.3 Spain: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.3.3.5.3.1 Spain: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.3.3.5.3.2 Spain: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.3.3.5.3.3 Spain: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.3.3.5.4 Spain: America and Europe Eye Drops Market Breakdown, by Application
      • 10.3.3.5.4.1 Spain: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.3.3.5.5 Spain: America and Europe Eye Drops Market Breakdown, by Purchase Mode
    • 10.3.3.6 Rest of Europe: Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.6.1 Overview
      • 10.3.3.6.2 Rest of Europe: America and Europe Eye Drops Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.3.3.6.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Drug Class
      • 10.3.3.6.3.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Antibiotics
      • 10.3.3.6.3.2 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Artificial Tears
      • 10.3.3.6.3.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Steroids
      • 10.3.3.6.4 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Application
      • 10.3.3.6.4.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Eye Diseases
      • 10.3.3.6.5 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Purchase Mode

11. Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the America and Europe Eye Drops Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Alcon AG
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 AbbVie Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Bausch & Lomb Inc
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Pfizer Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Prestige Consumer Healthcare Inc.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Similasan Corp
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Rohto Pharmaceutical Co Ltd
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Sager Pharma Kft
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Akorn Operating Company LLC
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Santen Pharmaceutical Co., Ltd.
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
• 12.11 SERVImed Industrial S.p.A.
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments
• 12.12 I-MED Pharma Inc.
  • 12.12.1 Key Facts
  • 12.12.2 Business Description
  • 12.12.3 Products and Services
  • 12.12.4 Financial Overview
  • 12.12.5 SWOT Analysis
  • 12.12.6 Key Developments

13. Appendix

• 13.1 About The Insight Partners